Figure 6

PEP-1-CAT inhibited H/R-induced H9c2 apoptosis via p38, PI3K and Erk1/2 MAPK signaling pathways. (A) H9c2 apoptosis was assessed by Flow Cytometry. (B) Quantification of H9c2 apoptosis rate. *P<0.01 vs CTL; ^@P<0.01 vs H/R group; ^$P<0.01 vs H/R or PEP-1-CAT-treated group; ^&P<0.05 vs PEP-1-CAT-treated group; ^#P<0.05 vs PEP-1-CAT-treated group; n = 5.